Strategic Partnerships NOVI Health has recently announced collaborations with Novo Nordisk to expand access to structured weight care in Singapore and with MyOme for genomic analysis and polygenic risk modeling. This indicates openness to co-delivery and data-driven health initiatives, presenting a sales opportunity to offer complementary health-tech solutions, data integration capabilities, or expanded patient engagement platforms aligned with weight management and precision prevention.

Chronic Care Focus The company specializes in precision prevention and data-driven management for diabetes and metabolic diseases, serving both chronic condition patients and wellness enthusiasts. This creates a sales opening for scalable patient monitoring tools, continuous risk profiling, and lifestyle intervention programs that can be integrated into NOVI Health’s current care pathways.

Weight Care Expansion Recent press indicates a partnership to broaden access to structured weight care in Singapore. This signals a priority area where sales conversations could center on weight management platforms, digital coaching, remote monitoring, and outcomes analytics that align with Novo Nordisk’s weight management initiatives.

Data-Driven Telehealth NOVI Health emphasizes real time actionable insights and tailored interventions through technology-enabled clinical solutions. There is a clear opportunity to propose advanced analytics, patient dashboards, API integrations with EMR systems, and marketing automation to enhance engagement and outcomes tracking for both clinicians and patients.

Growth and Investment Footprint With Series A funding and notable board appointments, NOVI Health is in a growth phase and actively scaling. Sales opportunities exist for value-led partnerships, enterprise pilots, and multi-year contracts for platform access, professional services, and regional expansion support as they widen their geographic and service reach.